RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,433,648 | -53.4% | 3,056,819 | +9.3% | 0.00% | – |
| Q2 2023 | $3,076,431 | -7.5% | 2,796,755 | +0.1% | 0.00% | – |
| Q1 2023 | $3,325,015 | -15.5% | 2,794,130 | +5.8% | 0.00% | – |
| Q4 2022 | $3,934,433 | +43.4% | 2,640,559 | +56.9% | 0.00% | – |
| Q3 2022 | $2,743,000 | +105.0% | 1,682,941 | 0.0% | 0.00% | – |
| Q2 2022 | $1,338,000 | -55.8% | 1,682,941 | 0.0% | 0.00% | – |
| Q1 2022 | $3,029,000 | +4.5% | 1,682,941 | -0.7% | 0.00% | – |
| Q4 2021 | $2,898,000 | -19.2% | 1,694,462 | -2.6% | 0.00% | – |
| Q3 2021 | $3,585,000 | -6.1% | 1,740,346 | +5.3% | 0.00% | – |
| Q2 2021 | $3,816,000 | +17.6% | 1,652,060 | +42.0% | 0.00% | – |
| Q1 2021 | $3,246,000 | +1.4% | 1,163,596 | +3.5% | 0.00% | – |
| Q4 2020 | $3,202,000 | +40.3% | 1,123,920 | +3.4% | 0.00% | – |
| Q3 2020 | $2,283,000 | -55.4% | 1,087,128 | -3.4% | 0.00% | – |
| Q2 2020 | $5,119,000 | -36.9% | 1,125,042 | +13.3% | 0.00% | – |
| Q1 2020 | $8,117,000 | -52.4% | 993,409 | +6.9% | 0.00% | -100.0% |
| Q4 2019 | $17,037,000 | +62.2% | 929,452 | -2.0% | 0.00% | – |
| Q3 2019 | $10,504,000 | +12.6% | 948,059 | +3.4% | 0.00% | – |
| Q2 2019 | $9,327,000 | +90.2% | 917,121 | +9.6% | 0.00% | – |
| Q1 2019 | $4,903,000 | -11.6% | 836,539 | +7.1% | 0.00% | – |
| Q4 2018 | $5,548,000 | +4.0% | 781,321 | +4.1% | 0.00% | – |
| Q3 2018 | $5,336,000 | +41.7% | 750,416 | -0.0% | 0.00% | – |
| Q2 2018 | $3,767,000 | -48.3% | 750,478 | +13.5% | 0.00% | – |
| Q1 2018 | $7,283,000 | +11.3% | 661,473 | -6.5% | 0.00% | – |
| Q4 2017 | $6,541,000 | +9.3% | 707,140 | +6.1% | 0.00% | – |
| Q3 2017 | $5,983,000 | +32.9% | 666,252 | +4.1% | 0.00% | – |
| Q2 2017 | $4,501,000 | -8.2% | 640,208 | +14.2% | 0.00% | – |
| Q1 2017 | $4,901,000 | +56.6% | 560,688 | +44.4% | 0.00% | – |
| Q4 2016 | $3,129,000 | +46.1% | 388,196 | +60.3% | 0.00% | – |
| Q3 2016 | $2,141,000 | +151.3% | 242,183 | +125.8% | 0.00% | – |
| Q2 2016 | $852,000 | +33.5% | 107,252 | +0.4% | 0.00% | – |
| Q1 2016 | $638,000 | -33.6% | 106,852 | 0.0% | 0.00% | – |
| Q4 2015 | $961,000 | -22.5% | 106,852 | +3.7% | 0.00% | – |
| Q3 2015 | $1,240,000 | +41.1% | 103,052 | +51.5% | 0.00% | – |
| Q2 2015 | $879,000 | +230.5% | 68,026 | +131.9% | 0.00% | – |
| Q1 2015 | $266,000 | +285.5% | 29,336 | +22.1% | 0.00% | – |
| Q4 2014 | $69,000 | -2.8% | 24,036 | 0.0% | 0.00% | – |
| Q3 2014 | $71,000 | – | 24,036 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |